
Extended-spectrum beta-lactamase-producing community-acquired urinary tract infections in children: Chart review of risk factors
Author(s) -
Sundaram Balasubramanian,
Dhanalakshmi Kuppuswamy,
Swathi Padmanabhan,
Vaishnavi Chandramohan,
Sumanth Amperayani
Publication year - 2018
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.246391
Subject(s) - medicine , urinary system , amoxicillin , clavulanic acid , antibiotics , piperacillin , tazobactam , cephalosporin , beta lactamase , piperacillin/tazobactam , risk factor , antimicrobial , antibiotic resistance , microbiology and biotechnology , biology , bacteria , imipenem , biochemistry , escherichia coli , gene , genetics , pseudomonas aeruginosa
Community acquired urinary tract infections (CA-UTI) caused by extended spectrum beta lactamase (ESBL) producing organisms is on the rise throughout the world. There are known risk factors such as age <1 year, children on uroprophylaxis, recurrent UTI, recent antibiotic usage etc which can predict the occurrence of these ESBL producers.